Gyre Therapeutics, Inc.

NASDAQ:GYRE

Biotechnology

Healthcare
$4.34 -0.15%

+$0.00 today

Market cap
$475.02M
Beta
4.92
P/E (TTM)
-88.3
EPS (TTM)
-$0.07
52W Low $5.44High $9.42

Volume 0.47M

Average 0.09M

Price history

Gyre Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-42.67%

Period high

$8.76

Period low

$4.01

Latest

$4.34

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 6, 2026Nov 5, 2026
8-KNov 5, 2026Nov 5, 2026
8-KOct 22, 2026Oct 22, 2026
8-KSep 1, 2026Sep 1, 2026
S-8Aug 27, 2026Aug 28, 2026
8-KAug 26, 2026Aug 26, 2026
10-QAug 7, 2026Aug 7, 2026
8-KAug 7, 2026Aug 7, 2026
3Aug 4, 2026Aug 4, 2026
4Aug 4, 2026Aug 4, 2026
4Aug 4, 2026Aug 4, 2026
3Aug 4, 2026Aug 4, 2026
EFFECTAug 3, 2026Aug 4, 2026
8-KJul 16, 2026Jul 16, 2026
8-K/AJul 15, 2026Jul 15, 2026

Competitors

Who does Gyre Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about GYRE's filings, answered from its disclosures.

What is the latest GYRE filing?

The latest filing shown is 10-Q dated Nov 6, 2026.

How many recent filings does GYRE have?

Intrinsic Alpha currently shows 20 recent filings for GYRE.